Investments Report with Dr. Mark A. Goldberg

Industry Featured Article

The interview conducted by Investment Reports features Mark Goldberg, Chairman and CEO of Allucent, discussing the company’s innovative approach to healthcare technology. Goldberg highlights the company’s dedication to revolutionizing healthcare through their state-of-the-art products, with a focus on improving patient outcomes and streamlining medical procedures.

Read Article Here

Mark A. Goldberg, M.D.

Chairman and CEO

Partner With the A-Team

Let us know how we can help you bring new therapies to light. Get in touch to get started.

Get In Touch

Join the A-Team

Want to help small and mid-sized biotech companies change the therapeutic landscape?

View Open Jobs

Solutions

Translational Clinical Pharmacology in Cell and Gene Therapy

Strengthen Your Regulatory Submissions Through Strategic Storyboarding

Therapeutic Expertise

Therapeutic Areas

Cross-Over Therapeutics

Advancing Oncology Research: Regulatory & Development Path for ADCs & Radionuclide Conjugates

Crossover Designs in Oncology: Statistical Perspectives

Company

Allucent Names Paula Brown Stafford as CEO Industry Veteran to Lead Next Phase of Global CRO’s Expansion

Allucent Awarded BARDA Contract to Support Acceleration of Next-Generation COVID-19 Booster Vaccines

Resources

Enabling Patient-Centric Drug Development: Opportunity for Clinical Pharmacology to Leverage Innovation and Advance Diversity and Inclusion in Clinical Trials

Achieving Operational Excellence in Clinical Research Organizations: A Catalyst for Biotech Success

Careers

Watch Our Corporate Video